THE OPTIMAL DOSAGE OF (-)DEPRENYL FOR INCREASING SUPEROXIDE-DISMUTASE ACTIVITIES IN SEVERAL BRAIN-REGIONS DECREASES WITH AGE IN MALE FISCHER 344 RATS

被引:41
作者
CARRILLO, MC
KANAI, S
SATO, Y
NOKUBO, M
IVY, GO
KITANI, K
机构
[1] UNIV TOKYO, FAC MED,RADIOISOTOPE RES INST,7-3-1 HONGO, BUNKYO KU, TOKYO 113, JAPAN
[2] TOKYO METROPOLITAN GERIATR HOSP & INST GERONTOL, DEPT CLIN PHYSIOL, ITABASHI KU, TOKYO 173, JAPAN
[3] UNIV TORONTO, DIV LIFE SCI, SCARBOROGH M1C 1A4, ON, CANADA
[4] UNIV NACL ROSARIO, INST FISIOL EXPTL SUIPACHA 570, RA-2000 ROSARIO, ARGENTINA
关键词
D O I
10.1016/0024-3205(93)90633-E
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We previously reported that the optimal dosage of (-)deprenyl to increase superoxide dismutase (SOD) activities in striatum in rats differs 10 fold between young male and female rats (1). Furthermore, in female rats the optimal dosage increased with age (1). In the present study in order to clarify how the optimal dosage of this effect changes with age in male rats, we examined the effects of four different dosages of deprenyl on SOD enzyme activities in striatum and several other tissues in old (28-29-month-old) male Fischer 344 (F-344) rats. Continuous s.c. infusion of deprenyl for 3 wks increased activities of SOD and catalase (CAT) in striatum, substantia nigra and cortical regions but not in hippocampus, cerebellum or the liver. The dose of 0.5 mg/kg/day was found to be most effective, while higher (1.0, 2.0 mg/kg/day) or lower (0.1 mg/kg/day) dosages were less effective. This value of 0.5 mg/kg/day was 4 fold lower than the dosage of 2.0 mg/kg/day which was most effective in increasing SOD and CAT activities in young (5-7 month old) male rats of the same strain (1,2). The decline of the optimal dosage with age found in male rats is best explained by a possible decline with age in the hepatic microsomal monooxygenase enzyme activities that are involved with the metabolism of deprenyl. In view of the large differences in the optimal dosages shown among different sexes and ages of rats, future studies regarding the unique effect of this drug in prolonging the life span of rats must be carefully investigated with the caution in mind that the optimal dosage for the life prolonging effect may well differ depending on sex, age and possibly strain and species of animal model used.
引用
收藏
页码:1925 / 1934
页数:10
相关论文
共 20 条
[1]  
BEERS RF, 1952, J BIOL CHEM, V195, P133
[2]   MONOAMINE-OXIDASE, BRAIN AGING AND DEGENERATIVE DISEASES [J].
BENEDETTI, MS ;
DOSTERT, P .
BIOCHEMICAL PHARMACOLOGY, 1989, 38 (04) :555-561
[3]   (-) DEPRENYL INDUCES ACTIVITIES OF BOTH SUPEROXIDE-DISMUTASE AND CATALASE BUT NOT OF GLUTATHIONE-PEROXIDASE IN THE STRIATUM OF YOUNG MALE-RATS [J].
CARRILLO, MC ;
KANAI, S ;
NOKUBO, M ;
KITANI, K .
LIFE SCIENCES, 1991, 48 (06) :517-521
[4]   (-) DEPRENYL INCREASES ACTIVITIES OF SUPEROXIDE-DISMUTASE AND CATALASE IN STRIATUM BUT NOT IN HIPPOCAMPUS - THE SEX AND AGE-RELATED DIFFERENCES IN THE OPTIMAL DOSE IN THE RAT [J].
CARRILLO, MC ;
KANAI, S ;
NOKUBO, M ;
IVY, GO ;
SATO, Y ;
KITANI, K .
EXPERIMENTAL NEUROLOGY, 1992, 116 (03) :286-294
[5]   DIFFERENCE IN RESPONSE OF HEPATIC GLUTATHIONE-S-TRANSFERASE ACTIVITIES TO PROTEIN-FREE DIET BETWEEN YOUNG AND OLD C57/BL MALE-MICE [J].
CARRILLO, MC ;
SATO, Y ;
KANAI, S ;
NOKUBO, M ;
KITANI, K .
MECHANISMS OF AGEING AND DEVELOPMENT, 1992, 65 (2-3) :301-311
[6]   THE ABILITY OF (-)DEPRENYL TO INCREASE SUPEROXIDE-DISMUTASE ACTIVITIES IN THE RAT IS TISSUE AND BRAIN REGION SELECTIVE [J].
CARRILLO, MC ;
KITANI, K ;
KANAI, S ;
SATO, Y ;
IVY, GO .
LIFE SCIENCES, 1992, 50 (25) :1985-1992
[7]   INHIBITION OF NITRITE FORMATION FROM HYDROXYLAMMONIUM-CHLORIDE - SIMPLE ASSAY FOR SUPEROXIDE-DISMUTASE [J].
ELSTNER, EF ;
HEUPEL, A .
ANALYTICAL BIOCHEMISTRY, 1976, 70 (02) :616-620
[8]   AGE AND SEX ASSOCIATED DIFFERENCES IN THE RELATIVE ABUNDANCE OF MULTIPLE SPECIES OF CYTOCHROME-P-450 IN RAT-LIVER MICROSOMES - A SEPARATION BY HPLC OF HEPATIC-MICROSOMAL CYTOCHROME-P-450 SPECIES [J].
FUJITA, S ;
KITAGAWA, H ;
CHIBA, M ;
SUZUKI, T ;
OHTA, M ;
KITANI, K .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (10) :1861-1864
[9]  
KAMATAKI T, 1985, J PHARMACOL EXP THER, V233, P222
[10]   METABOLISM OF (-) DEPRENYL TO AMPHETAMINE AND METHAMPHETAMINE MAY BE RESPONSIBLE FOR DEPRENYL THERAPEUTIC BENEFIT - A BIOCHEMICAL ASSESSMENT [J].
KAROUM, F ;
CHUANG, LW ;
EISLER, T ;
CALNE, DB ;
LIEBOWITZ, MR ;
QUITKIN, FM ;
KLEIN, DF ;
WYATT, RJ .
NEUROLOGY, 1982, 32 (05) :503-509